SEARCH

SEARCH BY CITATION

References

  • Angelin A, Tiepolo T, Sabatelli P, Grumati P, Bergamin N, Golfieri C et al. (2007). Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc Natl Acad Sci USA 104: 991996.
  • Arora K, Gwinn WM, Bower MA, Watson A, Okwumabua I, MacDonald HR et al. (2005). Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol 175: 517522.
  • Bell A, Monaghan P, Page AP (2006). Peptidyl-prolyl cis-trans isomerases (immunophilins) and their roles in parasite biochemistry, host-parasite interaction and antiparasitic drug action. Int J Parasitol 36: 261276.
  • Bobardt M, Tang H, Sakamoto N, Coelmont L, Neyts J, Dumont J-M (2008). The isomerase activity of cyclophilin A is critical for HCV replication. 15th International Symposium on Hepatitis C Virus & Related Viruses, San Antonio, Texas.
  • Bonaldo P, Braghetta P, Zanetti M, Piccolo S, Volpin D, Bressan GM (1998). Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum Mol Genet 7: 21352140.
  • Boncristiano M, Rossi Paccani S, Barone S, Ulivieri C, Patrussi L, Ilver D et al. (2003). The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J Exp Med 198: 18871897.
  • Borel JF, Feurer C, Magnee C, Stahelin H (1977). Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology 32: 10171025.
  • Cereghetti GM, Stangherlin A, Martins de Brito O, Chang CR, Blackstone C, Bernardi P et al. (2008). Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci USA 105: 1580315808.
  • Chatterji U, Bobardt MD, Stanfield R, Ptak RG, Pallansch LA, Ward PA et al. (2005). Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells. J Biol Chem 280: 4029340300.
  • Clipstone NA, Crabtree GR (1992). Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357: 695697.
  • Connern CP, Halestrap AP (1992). Purification and N-terminal sequencing of peptidyl-prolyl cis- trans-isomerase from rat liver mitochondrial matrix reveals the existence of a distinct mitochondrial cyclophilin. Biochem J 284: 381385.
  • Costantini P, Petronilli V, Colonna R, Bernardi P (1995). On the effects of paraquat on isolated mitochondria. Evidence that paraquat causes opening of the cyclosporin A-sensitive permeability transition pore synergistically with nitric oxide. Toxicology 99: 7788.
  • Damsker JM, Bukrinsky MI, Constant SL (2007). Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A. J Leukoc Biol 82: 613618.
  • Fischer G, Wittmann-Liebold B, Lang K, Kiefhaber T, Schmid FX (1989). Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337: 476478.
  • Flisiak R, Horban A, Gallay P, Bobardt M, Selvaraiah S, Wiercinska-Drapalo A et al. (2008). The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus. Hepatology 47: 817826.
  • Flisiak R, Dumont JM, Crabbe R (2007). Cyclophilin inhibitors in hepatitis C viral infection. Expert Opin Investig Drugs 16: 13451354.
  • Flisiak R, Feinman SV, Jablkowski M, Horban A, Kryczka W, Pawlowska M et al. (2009). The cyclophilin inhibitor Debio 025 combined with peg-IFNa2a significantly reduces viral load in treatment naïve hepatitis C patients. Hepatology 49: 14601468.
  • Fontaine E, Eriksson O, Ichas F, Bernardi P (1998a). Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation by electron flow through the respiratory chain complex I. J Biol Chem 273: 1266212668.
  • Fontaine E, Ichas F, Bernardi P (1998b). A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J Biol Chem 273: 2573425740.
  • Gomez L, Thibault H, Gharib A, Dumont J-M, Vuagniaux G, Scalfaro P et al. (2007). Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am J Physiol Heart Circ Physiol 293: H1654H1661.
  • Hansson MJ, Mattiasson G, Mansson R, Karlsson J, Keep MF, Waldmeier P et al. (2004). The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria. J Bioenerg Biomembr 36: 407413.
  • Inoue K, Umehara T, Ruegg UT, Yasui F, Watanabe T, Yasuda H et al. (2007). Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo. Hepatology 45: 921928.
  • Irwin W, Fontaine E, Agnolucci L, Penzo D, Betto R, Bortolotto S et al. (2002). Bupivacaine myotoxicity is mediated by mitochondria. J Biol Chem 277: 1222112227.
  • Irwin WA, Bergamin N, Sabatelli P, Reggiani C, Megighian A, Merlini L et al. (2003). Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat Genet 35: 267271.
  • Janssen PM, Zeitz O, Keweloh B, Siegel U, Maier LS, Barckhausen P et al. (2000). Influence of cyclosporine A on contractile function, calcium handling, and energetics in isolated human and rabbit myocardium. Cardiovasc Res 47: 99107.
  • Jin ZG, Lungu AO, Xie L, Wang M, Wong C, Berk BC (2004). Cyclophilin A is a proinflammatory cytokine that activates endothelial cells. Arterioscler Thromb Vasc Biol 24: 11861191.
  • Kaul A, Stauffer S, Schmitt J, Pertel T, Luban J, Bartenschlager R (2008). Role of cyclophilins in hepatitis C virus replication. 15th International Symposium on Hepatitis C Virus & Related Viruses, San Antonio, Texas.
  • Kim H, Kim WJ, Jeon ST, Koh EM, Cha HS, Ahn KS et al. (2005). Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages. Clin Immunol 116: 217224.
  • Kim SH, Lessner SM, Sakurai Y, Galis ZS (2004). Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction. Am J Pathol 164: 15671574.
  • Kong W, Li S, Longaker MT, Lorenz HP (2007). Cyclophilin C-associated protein is up-regulated during wound healing. J Cell Physiol 210: 153160.
  • Liu J, Farmer JDJ, Lane WS, Friedman J, Weissman I, Schreiber SL (1991). Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807815.
  • Merlini L, Bernardi P (2008). Therapy of collagen VI-related myopathies (Bethlem and Ullrich). Neurotherapeutics 5: 613618.
  • Merlini L, Angelin A, Tiepolo T, Braghetta P, Sabatelli P, Zamparelli A et al. (2008). Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc Natl Acad Sci USA 105: 52255229.
  • Millay DP, Sargent MA, Osinska H, Baines CP, Barton ER, Vuagniaux G et al. (2008). Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat Med 14: 442447.
  • Nicolli A, Basso E, Petronilli V, Wenger RM, Bernardi P (1996). Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, a cyclosporin A-sensitive channel. J Biol Chem 271: 21852192.
  • Paeshuyse J, Kaul A, De Clercq E, Rosenwirth B, Dumont JM, Scalfaro P et al. (2006). The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro. Hepatology 43: 761770.
  • Palma E, Tiepolo T, Angelin A, Sabatelli P, Maraldi NM, Basso E et al. (2009). Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice. Hum Mol Genet 126 : 18: 20242031.
  • Plyte S, Boncristiano M, Fattori E, Galvagni F, Rossi Paccani S, Majolini MB et al. (2001). Identification and characterization of a novel nuclear factor of activated T-cells-1 isoform expressed in mouse brain. J Biol Chem 276: 1435014358.
  • Ptak RG, Gallay PA, Jochmans D, Halestrap AP, Ruegg UT, Pallansch LA et al. (2008). Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent. Antimicrob Agents Chemother 52: 13021317.
  • Rasola A, Bernardi P (2007). The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12: 815833.
  • Reutenauer J, Dorchies OM, Patthey-Vuadens O, Vuagniaux G, Ruegg UT (2008). Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. Br J Pharmacol 155: 574584.
  • Sokolskaja E, Luban J (2006). Cyclophilin, TRIM5, and innate immunity to HIV-1. Curr Opin Microbiol 9: 404408.
  • Waldmeier PC, Feldtrauer JJ, Qian T, Lemasters JJ (2002). Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. Mol Pharmacol 62: 2229.
  • Waldmeier PC, Zimmermann K, Qian T, Tintelnot-Blomley M, Lemasters JJ (2003). Cyclophilin D as a drug target. Curr Med Chem 10: 14851506.
  • Walsh CT, Zydowsky LD, McKeon FD (1992). Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transduction. J Biol Chem 267: 1311513118.
  • Wang P, Heitman J (2005). The cyclophilins. Genome Biol 6: 226.1226.6.
  • Woodfield KY, Price NT, Halestrap AP (1997). cDNA cloning of rat mitochondrial cyclophilin. Biochim Biophys Acta 1351: 2730.
  • Yao Q, Li M, Yang H, Chai H, Fisher W, Chen C (2005). Roles of cyclophilins in cancers and other organ systems. World J Surg 29: 276280.
  • Zydowsky LD, Etzkorn FA, Chang HY, Ferguson SB, Stolz LA, Ho SI et al. (1992). Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition. Protein Sci 1: 10921099.